Contractors / Amerisourcebergen Drug Corp
Amerisourcebergen Drug Corp
prime recipient of federal awards · Subsidiary of Cencora, Inc. ≈ inferred · UEI KABZK8W6PQT3 ✓ from source
$7.4B
obligated · FY2025
4
funding agencies
100%
from Defense
0%
single-source
2
states
100%
in Pennsylvania
5
industries
≈ computedSingle-source: 0% of this recipient’s $7.4B in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.
Obligations by year
≈ computed$2.2B
FY20
$2.1B
FY21
$2B
FY22
$4.4B
FY23
$6.1B
FY24
$7.4B
FY25
▲ 239%
since FY20
Where this money comes from
✓ from sourceFUNDING AGENCIES
AMERISOURCEBERGEN DRUG C
Defense
$7.4B
3 other agencies
$0B
Amerisourcebergen Drug Corp
$7.4B
FY2025 obligated
Biggest awards (total value)
No awards yet.
What it does (NAICS / PSC)
Where the work lands
Pennsylvania✓ from source$7.4B
Illinois✓ from source$18.5K
Competitors
DMS Pharmaceutical Group Inc≈ computed$15.2M
Glaxosmithkline, LLC≈ computed$2.4M
Medline Industries, LP≈ computed$224.7K
Mckesson Corporation≈ computed$34.9K
Concordance Healthcare Solutions LLC≈ computed$33.3K
Alvogen, Inc.≈ computed$1.5K
Sanofi Vaccines US Inc.≈ computed$1.1K
computed from shared NAICS, not a stated rivalry.
Corporate family
Single registration: no combined family.
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.